1.	Phase I Study of Intratumoral Injection of Adenovirus-Mediated Human Interleukin-12 in Women With Liver Metastases Secondary to Breast Cancer Phase: Phase I Type: Treatment Status: Closed Age: 18 to 85 Sponsor: Other Protocol IDs: MTS-GCO-97-779, MTS-9911-358, MTS-A-8200, NCT00301106
2.	Vector Delivery of the IL-12 Gene in Men With Prostate Cancer Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: #H-6836, P50-CA58204, NCT00406939
3.	Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma Phase: Phase I Type: Treatment Status: Closed Age: 18 to 75 Sponsor: Pharmaceutical / Industry Protocol IDs: RTS-M101B', NIH OBA 0710-881, NCT00815607